Outset Medical (OM) Preferred Stock Liabilities (2018 - 2020)

Outset Medical (OM) has 3 years of Preferred Stock Liabilities data on file, last reported at $452.3 million in Q2 2020.

• Preferred Stock Liabilities for Q2 2020 came in at $452.3 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2020 was $452.3 million (changed N/A YoY), and the FY2019 annual result was $409.4 million, up 4.37% from the prior year.
• Preferred Stock Liabilities held at $452.3 million in Q2 2020 per OM's latest filing, from $452.3 million in the prior quarter.
• Over five years, Preferred Stock Liabilities peaked at $452.3 million in Q1 2020 and troughed at $392.3 million in Q4 2018.
• A 3-year average of $423.1 million and a median of $409.4 million in 2019 frame the typical range for Preferred Stock Liabilities.
• On a YoY basis, Preferred Stock Liabilities climbed as much as 4.37% in 2019 and fell as far as 4.37% in 2019.
• A 3-year view of Preferred Stock Liabilities shows it stood at $392.3 million in 2018, then grew by 4.37% to $409.4 million in 2019, then rose by 10.46% to $452.3 million in 2020.
• Business Quant data shows OM's Preferred Stock Liabilities at $452.3 million in Q2 2020, $452.3 million in Q1 2020, and $409.4 million in Q4 2019.